Results 361 to 370 of about 211,753 (383)

Recent progress in pancreatic cancer

Ca-A Cancer Journal for Clinicians, 2013
Christopher L Wolfgang, Daniel A Laheru, Elliot Fishman   +2 more
exaly  

Hodgkin lymphoma: A review and update on recent progress

Ca-A Cancer Journal for Clinicians, 2018
Satish P Shanbhag, Richard F Ambinder
exaly  

Establishing a more formal adverse drug reaction reporting system.

Hospital formulary, 1992
C S, Tse, A J, Madura
openaire   +1 more source

Adverse Drug Reaction Risk Measures: A Comparison of Estimates from Drug Surveillance and Randomised Trials

Pharmaceutical Medicine, 2019
Raphaelle Beau-Lejdstrom, Sarah Crook, A. Spanu, Tsung Yu, M. Puhan   +4 more
semanticscholar   +1 more source

Immunotherapy of cancer in 2012

Ca-A Cancer Journal for Clinicians, 2012
Lisa H Butterfield, Ahmad A Tarhini
exaly  

ASHP guidelines on adverse drug reaction monitoring and reporting. American Society of Hospital Pharmacy.

American Journal of Health-System Pharmacy, 1995

semanticscholar   +1 more source

Patient adherence and persistence with oral anticancer treatment

Ca-A Cancer Journal for Clinicians, 2009
Kathryn J Ruddy, Ann H Partridge
exaly  

Adverse drug reactions: Analysis of spontaneous reporting system in Europe in 2007–2009

European Journal of Clinical Pharmacology, 2012
Jindřich Srba, Veronika Deščíková, J. Vlček   +2 more
semanticscholar   +1 more source

Improving hospital adverse drug reaction reporting systems reduces hospitalisation costs

PharmacoEconomics & Outcomes News, 2001
openaire   +1 more source

Suspected Drug-Induced Hepatic Reactions Reported to the FDA's Adverse Reaction System: An Overview

Seminars in Liver Disease, 1981
openaire   +2 more sources